Scientific support services to conduct research related to the development, manufacture, and testing of cellular, tissue, and gene therapy products reviews and evaluates safety of human cells,…
Ended Awarded Last action
- Contract number
- 75F40122F19087
- Awardee
-
Midnight Sun Technologies LLC UEI ZKR5F6EZNAD2 Part of Kikiktagruk Inupiat Corp
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $335,564
Award facts
- Contract value 100% obligated
- $335,563.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- 8(a) Sole Source
- Competition
- Not Available for Competition Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$86,453 | |
| Exercise an Option | $211,008 | |
| Original award | $211,008 |
About this award
The Food and Drug Administration issued a delivery order to Midnight Sun Technologies LLC on September 1, 2022, under an 8(a) sole source set-aside with a ceiling value of $335,563.54 for scientific support services related to the development, manufacture, and testing of cellular, tissue, and gene therapy products.
Work performed at the FDA's Silver Spring, Maryland facility supports the safety review and evaluation of human cells, tissues, and cellular and tissue-based products. The ultimate completion date was September 7, 2024. Midnight Sun Technologies is an 8(a)-certified subsidiary of Kikiktagruk Inupiat Corporation, an Alaskan Native Corporation. The order was closed out through a final modification to de-obligate remaining funds.
Description
Scientific support services to conduct research related to the development, manufacture, and testing of cellular, tissue, and gene therapy products reviews and evaluates safety of human cells, tissues, and cellular and tissue-based products for risk
Quick answers
Who was awarded contract 75F40122F19087?
75F40122F19087 was awarded to Midnight Sun Technologies LLC by Food and Drug Administration (Department of Health and Human Services) on September 1, 2022.
How much is contract 75F40122F19087 worth?
The government has obligated $335,564 on 75F40122F19087.
Is contract 75F40122F19087 an order under another contract?
Yes. 75F40122F19087 is a delivery order under 75F40119D10015, an indefinite delivery contract.
Was contract 75F40122F19087 competed?
The extent of competition for 75F40122F19087 was not available for competition. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award